The combination of genistein with gefitinib, a drug widely used in the treatment of various cancers, can inhibit cell proliferation and induce apoptosis in drug resistant H1975 NSCLC cells, which harbor an epidermal growth factor receptor (EGFR) mutation [126]. This evidence concerns the gene EGFR and cancer.